These events contribute to the reduction of PDCD4 (the tumor suppressor protein), overexpression of IAP/MDR1 (P-gp), cell survival, and chemotherapeutic drug resistance in breast tumor cells. This evidence concerns the gene PDCD4 and breast neoplasm.